agreed @yelrom
to me there are two ways to look at this.
1. the easier path is to get a partnership for CLBP but not on favourable terms
OR
2. the harder path is, despite the SP and market turmoil, Mesoblast has the courage and conviction to push ahead with CLBP without a partner
a cynic May say that Mesoblast couldn’t get a partner for CLBP. I would like to think that Mesoblast couldn’t get the right partner nor terms.
IMO having the wrong partner in many ways is much worst than going solo
Ann: MSB Presents at Edison Group Global Healthcare Conference, page-63
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
-0.210(11.8%) |
Mkt cap ! $1.792B | |||
| Open | High | Low | Value | Volume |
| $1.72 | $1.74 | $1.52 | $15.63M | 9.716M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5127 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.57 | 39613 | 3 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |